Location History:
- North Plainfield, NJ (US) (2004 - 2008)
- Berkeley Heights, NJ (US) (2009 - 2016)
Company Filing History:
3 out of 4,770 
2 out of 3,684 
1 out of 35 
Years Active: 2004-2016
Title: The Innovative Contributions of Thorsten Rosner
Introduction
Thorsten Rosner is a notable inventor based in Berkeley Heights, NJ (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of five patents to his name, Rosner has made strides in developing novel compounds and processes that address critical health issues.
Latest Patents
One of Rosner's latest patents involves a process for the preparation of N,N-dicyclopropyl-4-(1,5-dimethyl-1H-pyrazol-3-ylamino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide. This invention relates to an improved method for synthesizing a compound currently in clinical trials for treating myeloproliferative disorders, including polycythaemia vera, thrombocythaemia, and primary myelofibrosis. Another significant patent pertains to CGRP receptor antagonists, which includes novel compounds that can be used in treating various CGRP-related disorders such as migraines, neurogenic inflammation, and chronic obstructive pulmonary disease (COPD).
Career Highlights
Throughout his career, Thorsten Rosner has worked with prominent companies in the pharmaceutical industry, including Merck & Company, Inc. and Bristol-Myers Squibb Company. His work has been instrumental in advancing therapeutic options for patients suffering from complex medical conditions.
Collaborations
Rosner has collaborated with esteemed colleagues, including Yi Xiao and Yongkui Sun, contributing to the innovative research and development of pharmaceutical solutions.
Conclusion
Thorsten Rosner's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to impact the treatment of various health disorders, showcasing the importance of innovation in medicine.